EMEA Auto-Injectors Market- Analysis, Share, Revenue, Growth Rate, Forecast - 2022

According to a report made available by Radiant Insights, Inc.; the auto-injectors market in Europe and Middle East & Africa (EMEA) is projected to attain significant growth in terms of revenue by 2022. It is anticipated to exhibit a high CAGR over the forecast period (2012 to 2022). Increasing prevalence of anaphylaxis, multiple sclerosis, high geriatric population, and production of biologics can play a major role in influencing market growth in the forthcoming years.

Auto-injectors or autoinjectors are the medical devices used for self-administration of medicines. They are mostly used for the treatment of anaphylaxis or allergy attacks. Auto injectors have a built-in safety mechanism to prevent needle injuries. Some of the devices are designed for a single use, after which they lock themselves. Rising cases of allergies and supportive government policies mandating autoinjectors on school campuses can benefit manufacturers in the near future.

Request Sample Report of EMEA Auto-Injectors Market here@ https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-auto-injectors-industry-2017/request-sample

Manufacturers in the auto-injectors market focus on improving needle strength and device materials to handle drug strength. They are integrating safety mechanisms to enhance the existing devices. Transition of the route of delivery from subcutaneous or muscular points to intradermal is expected to provide new avenues for development over the forecast period. Smart auto-injectors are also gaining focus in the European Union for the treatment of multiple sclerosis. Recently, Bayer Healthcare launched the first electronic autoinjector that can deliver BETASERON to multiple sclerosis patients. It can reduce the frequent inflammations caused by the disease.

The auto-injectors market in the Europe and Middle East & Africa is segmented on the basis of types, applications, and regions. By types, the market is split into disposable and reusable auto-injectors. Disposable devices are non-reusable after a single use, while the latter can be used by refilling the syringe with the appropriate drug. Concerns regarding needlestick injuries can lead to immense demand for disposable auto-injectors in the forthcoming years. Reusable autoinjectors are primarily used to deliver growth hormones.

Browse Complete Report Summary with TOC here: https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-auto-injectors-industry-2017

Major market applications comprise clinics, hospitals, and others. Hospitals and clinics can drive the demand for disposable auto-injectors to protect the medical staff from needle injuries. In addition, these devices can prove vital in case of a virus breakout. Clinics in the UK provide appropriate training to the first-time users about the drug administration and daily or weekly dosage. They provide these devices to opioid addicts to prevent any infections from these needles.

Regions covered in the EMEA market are South Africa, Algeria, Nigeria, Egypt, Benelux, France, Germany, Russia, United Kingdom (UK), Italy, Iran, Israel, Saudi Arabia, and United Arab Emirates (UAE). In 2016, the UK was one of the biggest market contributors followed by France and Germany. In May 2017, Schreiner MediPharm, a German label solution provider, has created special labels for autoinjectors with easily removable seals. The area beneath the label can be used for documenting patient information. It also comes with an integrated near-field communication (NFC) chip for additional authentication and security purposes.

Prominent players operating in the auto-injectors market are Novartis International AG; Sanofi S.A.; Mylan, Inc.; Ypsomed Holding AG; and Becton, Dickinson and Company (BD). Mylan dominated the global market due to its proprietary product, EpiPen. But the recent price hike and availability of generic versions forced the company to redevelop its marketing strategy. Ypsomed Holding AG recently launched its 2.25 ml disposable autoinjector. It can dispense higher volume of drugs. The company has also subsequently developed wearable injectors with the capacity to deliver biologic drugs intravenously.

Buy Complete EMEA Auto-Injectors Market Report @ https://www.radiantinsights.com/research/emea-europe-middle-east-and-africa-auto-injectors-industry-2017

About Us:
Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy.

Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com

This release was published on openPR.